Cite
HARVARD Citation
Vandenput, I. et al. (2011). Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer: Results From an Immunohistochemical Study. International journal of gynecological cancer. 21 (6), pp. 1071-1077. [Online].